CV Sciences (CVSI) Cost of Revenue (2013 - 2026)

CV Sciences has disclosed Cost of Revenue across 14 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Cost of Revenue fell 13.57% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $6.5 million (down 19.17% YoY), while the FY2025 annual figure was $7.0 million, down 17.57% from the prior year.
• Cost of Revenue came in at $1.5 million for Q2 2026 at CV Sciences, down from $1.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.3 million in Q1 2022 to a low of $1.5 million in Q2 2026.
• Average Cost of Revenue over 5 years is $2.1 million, with a median of $2.1 million recorded in 2024.
• The largest YoY upside for Cost of Revenue was 32.38% in 2022 against a maximum downside of 31.32% in 2022.
• Over 5 years, Cost of Revenue stood at $2.3 million in 2022, then declined by 10.75% to $2.1 million in 2023, then increased by 7.19% to $2.2 million in 2024, then dropped by 25.87% to $1.6 million in 2025, then declined by 6.17% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $1.5 million in Q2 2026, $1.6 million in Q1 2026, and $1.6 million in Q4 2025.